Grifols (NASDAQ:GRFS) Trading 6% Higher

Grifols, S.A. (NASDAQ:GRFS – Get Free Report)’s stock price traded up 6% during mid-day trading on Tuesday . The company traded as high as $10.56 and last traded at $10.41. 1,145,465 shares were traded during mid-day trading, an increase of 32% from the average session volume of 869,458 shares. The stock had previously closed at […]

Related Keywords

Canada ,United States ,Spain ,Vistaseal Veraseal ,Albutein Flexbag ,Susquehanna International Securities Ltd ,Quadrant Capital Group ,Ronald Blue Trust Inc ,Grifols Company Profile ,Morgan Stanley ,Get Free Report ,Financial Advisors ,Blue Trust ,Capital Group ,Susquehanna International Securities ,Gamunexc Immune Globulin Injection ,Flebogamma Immune Globulin Intravenous ,Xembify Immune Globulin Subcutaneous ,Immune Globulin ,Lynspad Alpha ,Proteinase Inhibitor ,Human Albumin ,Plasbumin Albumin ,Grifols Daily ,Grifols ,Nasdaq Grfs ,Grfs ,Medical ,Stocks ,Technicals ,